News Servier gets a win for cancer drug Tibsovo, bought in $1.8bn... Just three months after completing its $1.8 billion takeover of Agios' oncology pipeline, Servier has reported pos
News Sanofi’s rare disease drug Cablivi approved in the EU The European Commission has approved Sanofi’s Cablivi, the first treatment for patients with the rare blood-clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP), which is
News Ex-BioNTech execs launch 'AI-native' cancer company Two senior executives formerly at BioNTech have launched a new biotech, Bios Life, that they call "an AI-native cancer surveillance company."
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
